Therapy Clinical Trial - Probiotic After Acute Colonic Diverticulitis

Status Recruiting

Clinical Trial Summary

The goal of this observational study is to assess the efficacy and safety of the probiotic Escherichia coli Nissle 1917 (EcN®, Ca.Di.Group S.p.A) in the treatment of symptomatic patients after an episode of both complicated and uncomplicated acute colonic diverticulitis. The main question it aims to answer are: - Is the studied probiotic able to significantly reduce symptoms, assessed by means of a validated and dedicated score? - Is there any difference in microbiota among the study group at baseline and a selected cohort of patients subdivided in subjects with diverticulosis and asymptomatic subjects after an episode of acute uncomplicated diverticulitis or an episode of complicated diverticulitis submitted to surgery with colonic resection without stoma? - Is there any difference in microbiota in the study group at baseline and after 3 and 6 months of treatment with the probiotic? - Is there any correlation between microbiota modification and symptoms during follow-up? - Is there any impact on fecal calprotectin values before and during probiotic therapy? - Is there any modification of evacuation before and during follow-up? - Is probiotic able to prevent recurrent episodes of acute diverticulitis during follow-up? - The safety of the probiotic will be assessed during the follow-up. The study group will be assessed at baseline and during follow-up with a dedicated clinical score and Bristol stool scale. Microbiota and fecal calprotectin values will be also assessed at baseline and during follow-up. Microbiota at baseline will be also evaluated for comparison in the three selected groups with diverticulosis and both asymptomatic and symptomatic after an episode of acute diverticulitis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06040515
Study type	Observational
Source	University of Roma La Sapienza
Contact	Antonio Tursi, MD, PhD
Phone	+393473490583
Email	antotursi@tiscali.it
Status	Recruiting
Phase
Start date	May 1, 2023
Completion date	June 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03650543` - Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication	Phase 4
Recruiting	`NCT05788861` - Invasive Group A Streptococcal Infection
Completed	`NCT03712748` - Online Imaginal Exposure	N/A
Completed	`NCT01031667` - Synergistic Effect of Combination Therapy With Cilostazol and Probucol on Plaque Stabilization and Lesion Regression: Serial Intravascular Ultrasound and Virtual Histology Study(SECURE Study)	Phase 4
Recruiting	`NCT00226408` - Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon	Phase 3
Completed	`NCT05104957` - Evaluation of the Kinesiology Taping Effectiveness in the Treatment of Lumbar Spine Pain	N/A
Recruiting	`NCT06137053` - Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus
Completed	`NCT01023126` - Obesity and Psychotherapy as an Alternative to Treatment	N/A
Recruiting	`NCT05340738` - AI-Based Fidelity Feedback to Enhance CBT	N/A
Active, not recruiting	`NCT02455609` - Intrathecal Ketamine, Dexmedetomidine and Both With Bupivacaine for Postoperative Abdominal Cancer Surgery Pain	Phase 2/Phase 3
Completed	`NCT05261503` - Investigation of the Effectiveness of Environmental Enrichment-Based Intervention in Preterm Infants	N/A
Completed	`NCT04926311` - Efficiency of Speech and Language Intervention on Achievement of Children With Developmental Language Disorder
Recruiting	`NCT03721783` - Infant and Child European Cryoablation Project ICECaP
Recruiting	`NCT03283839` - Consequences of Temporomandibular Disorder on Balance Control	N/A
Recruiting	`NCT05901558` - Strategies for Toddler ASD With Remote-therapy (STAR) Model for ASD	N/A
Completed	`NCT03177863` - Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age	N/A
Recruiting	`NCT06146972` - Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis	Phase 4
Recruiting	`NCT03161249` - Psychoeducative Treatment of FEP With Mobile Training	N/A
Recruiting	`NCT04490317` - CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)
Completed	`NCT05591807` - Investigation to the Mechanism of the Neuroplastic Modulation in Central Auditory Tract